ZYNESP 40 INJECTION

Zynesp 40 Injection is a recombinant erythropoiesis-stimulating agent used to treat anemia associated with chronic kidney disease and chemotherapy. It contains darbepoetin alfa, which helps stimulate the bone marrow to produce more red blood cells, improving hemoglobin levels and reducing fatigue related to anemia. This injection is administered under medical supervision for safe and effective results.

Zynesp 40 Injection supports better oxygen delivery throughout the body, helping patients regain energy and maintain daily activity levels. It is commonly recommended in dialysis patients and cancer therapy cases where anemia is a frequent complication. Regular monitoring of hemoglobin levels is important to ensure optimal treatment response.

Zynesp 40 Injection ensures reliability, purity, and consistent therapeutic performance. It is widely supplied to hospitals, clinics, and global pharmaceutical buyers for dependable anemia management

Product Features

• Contains Darbepoetin Alfa 40mcg
• Stimulates red blood cell production
• Used for CKD and chemotherapy-related anemia
• Long-acting erythropoiesis-stimulating agent
• High-quality sterile injectable formulation

How It Helps

• Increases hemoglobin levels
• Reduces fatigue from anemia
• Improves oxygen delivery in the body
• Supports a better quality of life